Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Parkinson
27. May 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2879
Articles 1 - 20 / 57580
Enhancing sleep slow waves with auditory stimulation in people with Parkinson's disease: a randomized proof-of-concept trial.
Sci Rep
Schreiner SJ, Horlacher J, Fattinger S, Markert B, Renerts K, Brogli L, Kämpf L, Scandella M, Poryazova R, Valko PO, Ferster L, Sassenburg R, Jaramillo V, Da Poian G, Lustenberger C, Karlen W, Huber R, Baumann CR, Maric A.
PMID: 42191834 [PubMed - as supplied by publisher]
Do animal models represent the diversity of clinical Parkinson's disease?
Curr Opin Neurobiol
Massaro Cenere M, Schirinzi T, Ledonne A, Mercuri NB.
PMID: 42191412 [PubMed - as supplied by publisher]
Incidence of Dementia With Lewy Bodies in Salento, Italy: A Population-Based Study.
Neurology
Urso D, Giannoni-Luza S, Gnoni V, Giugno A, Rollo E, Mauro A, Sambati R, De Santis G, Alessandria M, Coluccia B, Panico NR, Cacciatore F, Vilella D, Zecca C, Ray N, Logroscino G, DLB Salento Study Group.
PMID: 42190148 [PubMed - indexed for MEDLINE]
Machine Learning Approaches to Early Detection of Parkinson's Disease Using Speech Analysis Technique.
Neurol Int
Hossain MA, Traini E, Amenta F.
PMID: 42188688 [PubMed]
Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024.
J Parkinsons Dis
Buff S, Pilcicka A, Pitzer K, Fiske B, Stott SR, McFarthing K.
PMID: 42187233 [PubMed - as supplied by publisher]
Impact and management of cognition on speech and swallow function in Parkinson's disease.
J Parkinsons Dis
Savage-Black M, Sevitz JS, Rogus-Pulia NM.
PMID: 42185736 [PubMed - as supplied by publisher]
GABAergic dysfunction in Parkinson's disease: insights from in vivo proton magnetic resonance spectroscopy.
NPJ Parkinsons Dis
Prasad S, Deelchand DK, Kumar M, Yadav R, Pal PK, Saini J.
PMID: 42185329 [PubMed - as supplied by publisher]
Functional bowel disorders in idiopathic Parkinson's disease: a Rome IV-based controlled study.
Neurodegener Dis Manag
Yavuz Z, Uzun M, Mutlu T, De, Çanakç, , Önder H, Melek , Çomo.
PMID: 42183722 [PubMed - as supplied by publisher]
Baseline predictors of response to a group-based speech and communication intervention in Parkinson's disease: A secondary analysis of a randomized controlled trial.
J Parkinsons Dis
Steurer H, Schalling E, Franzén E, Gustafsson JK, Albrecht F.
PMID: 42183643 [PubMed - as supplied by publisher]
The effect of combined motor and cognitive rehabilitation on motor performance in Parkinson's disease: a systematic review and meta-analysis.
J Rehabil Med
Cacciante L, Lando A, Ozcan EG, D'Imperio D, Meroni R, Guzik A, Dru, Cie, Kiper P.
PMID: 42183599 [PubMed - indexed for MEDLINE]
Altered regional homogeneity in Parkinson's disease with mild cognitive impairment: a resting-state fMRI study.
Front Psychol
Zhu X, Zhou J, Wei Q, Pu H, Chen Y, Zhu X, Li B, Liu S.
PMID: 42183505 [PubMed]
Predictive value of cerebrospinal fluid Alzheimer's disease biomarkers and neuropsychological measures for cognitive and motor outcomes in Parkinson's disease.
Brain Commun
Scalese A, Giuffrè GM, Di Lazzaro G, Cimmino AT, Musso F, Orsini M, Quaranta D, Vita MG, Piano C, Calabresi P, Marra C, Bentivoglio AR.
PMID: 42183041 [PubMed]
Entorhinal cortex atrophy mediates the association of plasma p-tau181, GFAP, and NfL with cognitive impairment in Parkinson's disease.
Front Aging Neurosci
Wan Q, Dai X, Zhang Z, Shan P, Mei G, Huang L, Wang L, Peng H.
PMID: 42182568 [PubMed]
Potential for distinguishing the parkinsonian subtype of multiple system atrophy from Parkinson's disease: a three-dimensional gait analysis study.
Front Aging Neurosci
Taximaimaiti R, Cai S, Li H.
PMID: 42182565 [PubMed]
Neurodegeneration at the crossroads: the gut-brain axis and blood-brain barrier in Parkinson's disease - a review.
Front Pharmacol
Gamal NK, Fakhry R, Hatem Y, Rashed E, Marzouk R, Bukr AKM, Akawi N, George MY.
PMID: 42181890 [PubMed]
Controlled Maxillofacial Administration of Levodopa in a Patient With Parkinson's Disease: A First-in-Human 24-Hour Follow-Up Study.
Cureus
Thirunavukarasu SC, Ramanan BBV, Varadharaj D, Arumugam D, Poyyadhappan J, Moorthy D, Benjamin SD, Verma K, Sudhakar J, Janardhanan HA, Ur A.
PMID: 42181371 [PubMed]
Integrating stakeholder perspectives in the co-design of medical device software to monitor Parkinson's disease symptoms- A case-study.
MethodsX
Raut RA, Polus B, Ngo QC, Pah ND, Clay-Williams R, Kumar DK.
PMID: 42181080 [PubMed]
Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.
Acta Pharm Sin B
Padilla AL, Lanciego JL, Vila M, de Castro F, Pozo D, Rodríguez de Fonseca F, Serrano A, Sáez-Valero J, Núñez L, Villalobos C, Tapias V.
PMID: 42180537 [PubMed]
Acupuncture effects on non-motor symptoms of Parkinson's disease (sleep, mood, and fatigue): a systematic review and meta-analysis.
Front Neurol
Cui Y, Xue R, Zhang B, Huo H, Zhang Q, Gao B, Zhao Y, Mao S, Zhong W, Zhao J.
PMID: 42180219 [PubMed]
Incidence of anxiety disorders following Parkinson's disease: a population-based cohort study.
Front Psychiatry
Bae Y, Han J, Jeon SR, Shin W, Dong JJ, Jung H, Lee SW.
PMID: 42179994 [PubMed]
Articles 1 - 20 / 57580
Page 1 of 2879
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy